Eventide Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.1M | Buy |
|
|||||
|
2025
Q1 | $78.8M | Buy |
|
|||||
|
2024
Q4 | $75.6M | Buy |
|
|||||
|
2024
Q3 | $102M | Buy |
|
|||||
|
2024
Q2 | $84.8M | Buy |
|
|||||
|
2024
Q1 | $102M | Buy |
|
|||||
|
2023
Q4 | $81M | Sell |
|
|||||
|
2023
Q3 | $58.8M | Buy |
|
|||||
|
2023
Q2 | $56.5M | Buy |
|
|||||
|
2023
Q1 | $63.1M | Buy |
|
|||||
|
2022
Q4 | $61M | Hold |
|
|||||
|
2022
Q3 | $42.1M | Hold |
|
|||||
|
2022
Q2 | $46.6M | Hold |
|
|||||
|
2022
Q1 | $53.5M | Hold |
|
|||||
|
2021
Q4 | $49.1M | Hold |
|
|||||
|
2021
Q3 | $51.9M | Hold |
|
|||||
|
2021
Q2 | $62.2M | Buy |
|
|||||
|
2021
Q1 | $57.5M | Hold |
|
|||||
|
2020
Q4 | $48.6M | Hold |
|
|||||
|
2020
Q3 | $50.5M | Hold |
|
|||||
|
2020
Q2 | $42.5M | Hold |
|
|||||
|
2020
Q1 | $39.6M | Hold |
|
|||||
|
2019
Q4 | $50M | Hold |
|
|||||
|
2019
Q3 | $27.9M | Hold |
|
|||||
|
2019
Q2 | $31.9M | Buy |
|
|||||
|
2019
Q1 | $33.4M | Hold |
|
|||||
|
2018
Q4 | $37.9M | Hold |
|
|||||
|
2018
Q3 | $32.5M | Hold |
|
|||||
|
2018
Q2 | $52.7M | Hold |
|
|||||
|
2018
Q1 | $56.4M | Hold |
|
|||||
|
2017
Q4 | $40.8M | Hold |
|
|||||
|
2017
Q3 | $23.2M | Hold |
|
|||||
|
2017
Q2 | $27.6M | Buy |
|
|||||
|
2017
Q1 | $21.7M | Buy |
|
|||||
|
2016
Q4 | $32.4M | Buy |
|
|||||
|
2016
Q3 | $38.7M | Buy |
|
|||||
|
2016
Q2 | $23.1M | Buy |
|
|||||
|
2016
Q1 | $33.9M | Buy |
|
|||||
|
2015
Q4 | $29.3M | Buy |
|
|||||
|
2015
Q3 | $21.6M | Buy |
|
|||||
|
2015
Q2 | $13.3M | Buy |
|